DNDi - NewsLetter


HOME
ABOUT DNDi EDITORIAL: "Key Challenges for Successful Partnerships" CALENDAR HOW YOU CAN HELP DNDi?
DNDi's Malaria Project: A Model for Innovative Partnerships? Fighting Malaria in the Legal Amazon, Brazil ASMQ in a Nutshell ASAQ: a new Business Model for a "Big Pharma" ASMQ: a Great Public-Private, Intercontinental Partnership Why Lead Platforms are Crucial to Boost Innovation for Neglected Diseases Asian Region Makes Use of its Biodiversity to Identify New Bioactive Molecules Our moral responsibility to address Public Health Issues Four Characteristics For Partnership Paving the Way to Win-Win Partnerships DNDi R&D Projects-2008 Outlook Synergise Efforts with Anacor, GSK, IRD, Eskitis, UNC, and Intitut Pasteur Korea. Operational Challenges: Clinical Trial Partnerships in Africa LEAP: 4 Years and Going Strong... Concentrated HAT Platform Efforts in the 5 Most Affected Countries Advances at the DNDi Regional Support Office KEMRI, Nairobi Actions to Increase Awareness and Visibility in the Asian Region DNDi's Launch of ASMQ in Rio de Janeiro DNDi Project Collaboration in Japan DNDi in DRC brings Regular Support to the Clinical Trials From Discovery to Clinical Trials in India DNDi Strengthens North American Presence DNDi Joins Scientists Without Borders^SM Fexinidazole: A Rediscovered Compound Progresses as a Preclinical Drug Candidate for HAT Neglected by Everybody: PLoS NTD Publishes Media Analysis on Neglected Diseases DNDi Participates at International Meeting on Chagas Disease DNDi Awarded by the French Societé de Pathologie Exotique DNDi Receives Goodwin Award for Its Social Entrepeneurial Approach for the Most Neglected Diversifying Sources of Funding News from Donors IGWG: An Important Step Towards Boosting Innovation Contact DNDi

Actions to Increase Awareness and Visibility in the Asian Region

Visweswaran Navaratnam,
Head of Regional Office,
Pulau, Malaysia

The main activities undertaken by the Malaysia Regional Office are to support DNDi projects in the region, to foster the establishment of natural substance discovery and development research consortia focusing on the identification of potential bioactive agents for neglected diseases, and to increase the awareness and visibility of DNDi regionally. The Regional Office is also taking steps to facilitate the implementation of ASMQ in the region through liaisons with relevant malaria control programmes and other relevant authorities. It also plays a role in scientific events that are organised in the region. DNDi hence has participated in the Asian Expert Forum on Malaria/TB/AIDS organised by the UN in Bangkok January 08. It also attended the ASEAN Drug Regulators Meeting that took place in March 2008.
For future events in the region, DNDi is sponsoring the Symposium on "Partnering in R&D to Develop New Drugs for the Most Neglected Diseases" which is due to take place on 22 June 2008 within the 13th International Congress on Infectious Disease.

Visit http://www.icid.org/13th_icid/

Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 - www.dndi.org